Author: He, Jiayang; Li, Zhengtu; Huang, Wanyi; Guan, Wenda; Ma, Hongxia; Yang, Zi feng; Wang, Xinhua
Title: Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial Document date: 2019_4_2
ID: vn9e5nm3_108
Snippet: The main index of treatment effectiveness is the period of time until subsidence of symptoms 402 (hours). It has been reported that the average period of time for remission of these symptoms in the be considered clinically significant, the mean time for symptomatic remission in the positive group 407 must less than 12 hours compared with the placebo group, which means the Permissible Error (ï¤) of 408 the superiority trial is within 12 hours. (T.....
Document: The main index of treatment effectiveness is the period of time until subsidence of symptoms 402 (hours). It has been reported that the average period of time for remission of these symptoms in the be considered clinically significant, the mean time for symptomatic remission in the positive group 407 must less than 12 hours compared with the placebo group, which means the Permissible Error (ï¤) of 408 the superiority trial is within 12 hours. (Table 6) 409 Based on the above data, the SAS Software was used to estimate the sample size required for 410 "One-way ANOVA". The calculation result is designed for 3 parallel groups. (Table 7) 411
Search related documents:
Co phrase search for related documents- average period and main index: 1, 2
- average period and mean time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- average period and parallel group: 1
- average period and placebo group: 1, 2, 3, 4, 5
- average period and positive group: 1, 2, 3, 4
- average period and positive group symptomatic remission: 1, 2
- average period and positive group symptomatic remission mean time: 1, 2
- average period and sample size: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- average period and superiority trial: 1, 2
- average period and symptomatic remission: 1, 2
- average period and time average period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- average period and time period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- average period and treatment effectiveness: 1, 2, 3, 4, 5, 6
- average period and treatment effectiveness main index: 1, 2
- calculation result and main index: 1
- calculation result and mean time: 1
- calculation result and placebo group: 1
- calculation result and positive group: 1
- calculation result and positive group symptomatic remission: 1
Co phrase search for related documents, hyperlinks ordered by date